FindTrial
Sign In

INCB106385

DRUG2 trials

Sponsors

Incyte Corporation

Conditions

Advanced Solid TumorsBladder CancerCastration Resistant Prostate CancerColorectal CancerGastric/ Gastroesophageal JunctionGastrointestinal (GI) MalignanciesHepatocellular CarcinomaNon Small Cell Lung Cancer

Phase 1

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
CompletedNCT04580485
Incyte CorporationBladder Cancer, Castration Resistant Prostate Cancer, Colorectal Cancer +8
Start: 2021-02-03End: 2024-01-22Updated: 2025-07-11
Study of INCA 0186 in Subjects With Advanced Solid Tumors
TerminatedNCT04989387
Incyte CorporationAdvanced Solid Tumors, Gastrointestinal (GI) Malignancies, Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Start: 2021-10-04End: 2024-09-19Updated: 2025-09-02

Related Papers

176P Phase I study of INCB106385 alone or in combination with immunotherapy in advanced solid tumors
Immuno-Oncology Technology2022-12-01